GFACX | OTFCX | GFACX / OTFCX | |
Total Expense Ratio | 1.36 | 1.71 | 80% |
Annual Report Gross Expense Ratio | 1.36 | 1.71 | 80% |
Fund Existence | 24 years | 32 years | - |
Gain YTD | 4.705 | -0.954 | -493% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 1000 | 25% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 306B | 5.61B | 5,457% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | 5.17 | 1.22 | 424% |
Returns for 3 years | 46.73 | 60.89 | 77% |
Returns for 5 years | 39.11 | 8.21 | 476% |
Returns for 10 years | 55.69 | -19.12 | -291% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ECHSX | 12.96 | -0.14 | -1.07% |
Eaton Vance Worldwide Health Sci C | |||
CGVFX | 25.68 | -0.33 | -1.27% |
American Funds Global Insight 529-F-1 | |||
IAVGX | 19.77 | -0.26 | -1.30% |
Voya Growth and Income Port A | |||
HSLSX | 38.82 | -0.64 | -1.62% |
Hartford Small Cap Growth R4 | |||
SEKAX | 19.75 | -0.39 | -1.94% |
DWS Emerging Markets Equity A |